- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 20, 2026 | 25.39M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 19.58M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 17.34M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 11M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 11M sh |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | −$8.79M |
| Operating Cash Flow restated | Q2 2026 · Mar 31, 2025 | −$56.49K |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $15.72K |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $15.72K |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $98.65M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $3.06M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | −$11.8M |
| Stockholders Equity restated | Q2 2026 · Mar 31, 2025 | −$303.69K |
| Stockholders Equity restated | Q2 2026 · Sep 30, 2024 | −$71.12K |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $37.06M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $14.49M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $37.06M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $14.49M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $15.12M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $2.69M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $135.7M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $2.69M |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$0.66 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$1.14 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | −$0.02 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$0.66 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$1.14 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | −$0.02 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $2.92M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $7.6M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $131.46K |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $275.23K |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $271.53K |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $586.61K |
| Net Income | Q2 2026 · Mar 31, 2026 | −$12.91M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$19.85M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$28.84K |
| Net Income restated | Q2 2026 · Mar 31, 2025 | −$232.57K |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$11.06M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$17.62M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | −$142.95K |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | −$346.68K |